AI-MIRACLE: Artificial Intelligence and MultIpaRAmetric MRI Predict CLinical OutcomEs to Neoadjuvant Immunotherapy in Patients with Muscle-invasive Bladder Cancer Undergoing Radical Cystectomy
Publication date: August 2026 Source: European Urology Oncology, Volume 9, Issue 4 Author(s): Andrea Necchi, Giorgio Brembilla, Karissa Whiting, Yuki Arita, Oguz Akin, Aditya Apte, Muhammad Awais, Alfonso Lema-Dopico, Ramesh Paudyal, Michele Cosenza, Brigida Anna Maiorano, Valentina Tateo, Antonio Cigliola, Chiara Mercinelli, Francesco De Cobelli, Marinela Capanu, Amita Shukla-Dave, Lawrence H. Schwartz
AI-MIRACLE: Artificial Intelligence and MultIpaRAmetric MRI Predict CLinical OutcomEs to Neoadjuvant Immunotherapy in Patients with Muscle-invasive Bladder Cancer Undergoing Radical Cystectomy. // European Urology Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S2588931126001331?dgcid=rss_sd_all
AI-MIRACLE: Artificial Intelligence and MultIpaRAmetric MRI Predict CLinical OutcomEs to Neoadjuvant Immunotherapy in Patients with Muscle-invasive Bladder Cancer Undergoing Radical Cystectomy. European Urology Oncology. https://www.sciencedirect.com/science/article/pii/S2588931126001331?dgcid=rss_sd_all
“AI-MIRACLE: Artificial Intelligence and MultIpaRAmetric MRI Predict CLinical OutcomEs to Neoadjuvant Immunotherapy in Patients with Muscle-invasive Bladder Cancer Undergoing Radical Cystectomy.” European Urology Oncology.
@article{article118631,
title = {AI-MIRACLE: Artificial Intelligence and MultIpaRAmetric MRI Predict CLinical OutcomEs to Neoadjuvant Immunotherapy in Patients with Muscle-invasive Bladder Cancer Undergoing Radical Cystectomy},
journal = {European Urology Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S2588931126001331?dgcid=rss_sd_all}
}
Objective To assess prostate‐specific antigen (PSA) testing according to income, age, and region of residence in Sweden. Patients and Methods We conducted a nationwide, population‐based open cohort study of men aged 40–90 years in...